TrialPloS one2015

Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial.

Seiji Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.